NEW YORK (GenomeWeb News) — The US Food and Drug Administration wants to find out what the scientific community thinks about how well the latest next-generation sequencing technologies perform, and to assess the pros and cons of these technologies and the new bioinformatics tools that are designed to work with them.
The agency is seeking volunteers from the public to participate in the Sequencing Quality Control project with the aim of providing objective assessments of DNA and RNA analysis technologies and the software designed to manage and analyze the “massive new data sets” that next-generation tools create.
The volunteers for this project, which is “a natural extension of the Microarray Quality Control project,” FDA said in a program solicitation, could include vendors of next-gen sequencing tools and institutions interested in generating, managing, analyzing, and interpreting data.
Requests to participate in the SEQC project at the National Center for Toxicological Research should be submitted by Jan. 9, 2009. More information about the project is available here.